$CING

Cingulate Inc. (NASDAQ: CING) has filed an S-3 shelf registration statement to register 4.21 million shares of common stock for resale by selling stockholders. These shares include those issued in a January 2026 private placement, shares from preferred stock conversion, and shares issuable upon warrant exercise. The company will not receive proceeds from resales, but could receive approximately $9.4 million if warrants are fully exercised for cash, which would be used for regulatory approval, development, manufacturing, and commercialization of CTx-1301.